Spondylitis, Ankylosing
60
3
5
38
Key Insights
Highlights
Success Rate
83% trial completion
Published Results
21 trials with published results (35%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 39/100
13.3%
8 terminated out of 60 trials
82.6%
-3.9% vs benchmark
42%
25 trials in Phase 3/4
55%
21 of 38 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 38 completed trials
Clinical Trials (60)
Natural History and Development of Spondyloarthritis
Effects of Phytocannabinoids on Immune Response and Autophagy During Chronic Immune-mediated Inflammatory Diseases
Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases
Spondylo-arthritis Screening Tool Among Patient Suffering From Inflammatory Bowel Disease
Enhanced Clinics for Patients Diagnosed With Ankylosing Spondylitis and Psoriatic Arthritis
A Study of Golimumab in the Treatment of Indian Participants With Active Spondyloarthropathy of Ankylosing Spondylitis or Psoriatic Arthritis
The Effect of Mobile Application on Subcutaneous Anti-TNF Drug Administration:Ankylosing Spondylitis Patients
Study of Gynecological Follow-up of Patients With Autoimmune Disease or Inflammatory Rheumatism
Characterization of Immunogenicity of TNF Inhibitors in Arthritis Patients With Poorer Treatment Response.
A Two-Part 26-Week Study of Etoricoxib as Treatment for Ankylosing Spondylitis (AS) (MK-0663-108)
A Study of CC-99677 in Participants With Active Ankylosing Spondylitis
The Relationship Between Inflammatory ARTritis and CArdiac DIseAse
Evaluation of Efficacy and Safety of Meloxicam Suppository (15mg Daily) and Tablet (15 mg Daily) Compared to Indomethacin Suppository (50 mg Daily) in Patients With Ankylosing Spondylitis
One-year Persistence to Treatment of Participants Receiving Flixabi or Imraldi: a French Cohort Study
Frequency of Pes Planus and Posterior Tibial Tendon Dysfunction in Patients With Ankylosing Spondylitis
Novel Quantitative MRI for Axial Spondyloarthritis
Survey About Diet in Chronic Inflammatory Rheumatic Diseases
Prediction of the Answer to the Treatment by Biotherapies for Naive Spondyloarthritis by Combinatorial Analysis of Serum Biomarkers
Treat-to-Target Strategy With Etanercept for Ankylosing Spondylitis
Prediction of Treatment Response at 6 Months by Combinatorial Analysis of Serum Biomarkers in Biotherapy Naive SpA